Komori
Occurring Fact4880CellSource Co.,Ltd.Pharmaceuticals

Notice Regarding the Relocation of the Head Office and the Expected Recognition of an Extraordinary Loss

The company has decided to relocate its head office and expects to recognize an extraordinary loss of ¥290 million in the fiscal year ending October 2026 in connection with the relocation. This comprises an impairment loss on fixed assets of ¥249 million and an addition to the provision for office relocation costs of ¥40 million.

Worth reading
51Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Deterioration
Direction inferred from the company’s description.
Scale
290
¥ million (extraordinary loss)
Wording
Avoiding a definitive answer
How definitive the wording is.

Notice Regarding the Relocation of the Head Office and the Expected Recognition of an Extraordinary Loss

Subject Entity

セルソース株式会社 (the Company)

Target Locations / Products

Head office (the office building currently occupied)

Occurrence8 September 2026 (the date on which the Board of Directors resolved to relocate the head office)
This disclosure09/08/2026
Cause

The fixed-term office lease for the office building currently occupied will expire on 28 February 2028.

Amount of Impact on Business Performance

¥290 million (an impairment loss on fixed assets of ¥249 million and an addition to the provision for office relocation costs of ¥40 million; extraordinary loss)

Accounting period in which recognized

Fiscal year ending October 2026

Impact on Earnings Forecast

Please also refer to the Notice Regarding Revisions to the Earnings Forecast, disclosed separately today.

Outlook

The new location will be disclosed promptly after the lease agreement has been executed. Any other impact of the head-office relocation on earnings will be disclosed promptly if the company determines that it will affect earnings.

Planned follow-up disclosure

The new location will be disclosed promptly after the lease agreement has been executed. The impact on earnings will also be disclosed promptly if the company determines that there will be an impact.

Event that occurred
ItemDetails
Event nameNotice Regarding the Relocation of the Head Office and the Expected Recognition of an Extraordinary Loss
Date of occurrence8 September 2026 (the date on which the Board of Directors resolved to relocate the head office)
Subject Entityセルソース株式会社 (the Company)
Target Locations / ProductsHead office (the office building currently occupied)
CauseThe fixed-term office lease for the office building currently occupied will expire on 28 February 2028.
Amount of Impact on Business Performance¥290 million (an impairment loss on fixed assets of ¥249 million and an addition to the provision for office relocation costs of ¥40 million; extraordinary loss)
Accounting period in which recognizedFiscal year ending October 2026
Impact on Earnings ForecastPlease also refer to the Notice Regarding Revisions to the Earnings Forecast, disclosed separately today.
OutlookThe new location will be disclosed promptly after the lease agreement has been executed. Any other impact of the head-office relocation on earnings will be disclosed promptly if the company determines that it will affect earnings.
Planned follow-up disclosureThe new location will be disclosed promptly after the lease agreement has been executed. The impact on earnings will also be disclosed promptly if the company determines that there will be an impact.
Items this document does not state (15)
Date recognized / date notice receivedType of litigation or proceedingCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityVoting rights ownership percentage before the changeVoting rights ownership percentage after the change

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The fixed-term office lease for the office building currently occupied will expire on 28 February 2028.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Relocation of the Head Office and the Expected Recognition of an Extraordinary Loss | CellSource Co.,Ltd. (4880) timely disclosure | Komori